uk
Feedback

Не попадись на ботовода! Telemetrio знаходить і позначає такі канали мітками 👉 Хочеш бачити мітку, оформляй підписку

JAMA (Journal of the American Medical Association)

JAMA (Journal of the American Medical Association)

Відкрити в Telegram

All the latest articles published on JAMA before going in to print Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicine_Bot

Показати більше

📈 Аналітичний огляд Telegram-каналу JAMA (Journal of the American Medical Association)

Канал JAMA (Journal of the American Medical Association) (@jamaupdates) у мовному сегменті Англійська є активним учасником. На даний момент спільнота об'єднує 17 106 підписників, посідаючи 1 451 місце в категорії Медицина та 2 164 місце у регіоні США.

📊 Показники аудиторії та динаміка

З моменту свого створення невідомо, проект продемонстрував стрімке зростання, зібравши аудиторію у 17 106 підписників.

За останніми даними від 20 листопада, 2026, канал демонструє стабільну активність. Хоча за останні 30 днів спостерігається зміна кількості учасників на 373, а за останні 24 години на 11, загальне охоплення залишається високим.

  • Статус верифікації: Не верифікований
  • Рівень залученості (ER): Середній показник залученості аудиторії становить 3.83%. Протягом перших 24 годин після публікації контент зазвичай збирає 1.77% реакцій від загальної кількості підписників.
  • Охоплення публікацій: В середньому кожен допис отримує 655 переглядів. Протягом першої доби публікація в середньому набирає 302 переглядів.
  • Реакції та взаємодія: Аудиторія активно підтримує контент: середня кількість реакцій на один пост – 1.
  • Тематичні інтереси: Контент зосереджений навколо ключових тем, таких як patient, disease, treatment, drug, guideline.

📝 Опис та контентна політика

Автор описує ресурс як майданчик для висловлення суб'єктивної думки:
“All the latest articles published on JAMA before going in to print Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicine_Bot”

Завдяки високій частоті оновлень (останні дані отримано 21 листопада, 2026), канал підтримує актуальність та високий рівень охоплення публікацій. Аналітика показує, що аудиторія активно взаємодіє з контентом, що робить його важливою точкою впливу в категорії Медицина.

17 106
Підписники
+1124 години
+777 днів
+37330 днів

Завантажуємо дані

Залучення підписників
лист '26
листопад '26
+320
в 1 каналах
жовтень '26
+291
в 0 каналах
Get PRO
вересень '26
+301
в 0 каналах
Get PRO
серпень '26
+361
в 0 каналах
Get PRO
липень '26
+440
в 0 каналах
Get PRO
червень '26
+422
в 1 каналах
Get PRO
травень '26
+584
в 0 каналах
Get PRO
квітень '26
+437
в 0 каналах
Get PRO
березень '26
+217
в 0 каналах
Get PRO
лютий '26
+247
в 0 каналах
Get PRO
січень '26
+321
в 0 каналах
Get PRO
грудень '25
+277
в 0 каналах
Get PRO
листопад '25
+366
в 2 каналах
Get PRO
жовтень '25
+164
в 0 каналах
Get PRO
вересень '25
+12
в 0 каналах
Get PRO
серпень '25
+29
в 0 каналах
Get PRO
липень '25
+30
в 0 каналах
Get PRO
червень '25
+17
в 0 каналах
Get PRO
травень '25
+9
в 0 каналах
Get PRO
квітень '25
+5
в 0 каналах
Get PRO
березень '25
+17
в 0 каналах
Get PRO
лютий '25
+12
в 0 каналах
Get PRO
січень '25
+18
в 1 каналах
Get PRO
грудень '24
+237
в 0 каналах
Get PRO
листопад '24
+1 122
в 0 каналах
Get PRO
жовтень '24
+1 120
в 0 каналах
Get PRO
вересень '24
+1 527
в 1 каналах
Get PRO
серпень '24
+1 128
в 1 каналах
Get PRO
липень '24
+1 216
в 0 каналах
Get PRO
червень '24
+781
в 1 каналах
Get PRO
травень '24
+797
в 1 каналах
Get PRO
квітень '24
+808
в 1 каналах
Get PRO
березень '24
+821
в 2 каналах
Get PRO
лютий '24
+753
в 1 каналах
Get PRO
січень '24
+768
в 0 каналах
Get PRO
грудень '23
+716
в 1 каналах
Get PRO
листопад '23
+96
в 1 каналах
Get PRO
жовтень '23
+86
в 0 каналах
Get PRO
вересень '23
+73
в 0 каналах
Get PRO
серпень '23
+90
в 0 каналах
Get PRO
липень '23
+107
в 0 каналах
Get PRO
червень '23
+105
в 0 каналах
Get PRO
травень '23
+169
в 0 каналах
Get PRO
квітень '23
+128
в 0 каналах
Get PRO
березень '23
+84
в 0 каналах
Get PRO
лютий '23
+75
в 0 каналах
Get PRO
січень '23
+71
в 0 каналах
Get PRO
грудень '22
+74
в 0 каналах
Get PRO
листопад '22
+149
в 0 каналах
Get PRO
жовтень '22
+90
в 0 каналах
Get PRO
вересень '22
+138
в 0 каналах
Get PRO
серпень '22
+77
в 0 каналах
Get PRO
липень '22
+50
в 0 каналах
Get PRO
червень '22
+96
в 0 каналах
Get PRO
травень '22
+75
в 0 каналах
Get PRO
квітень '22
+80
в 0 каналах
Get PRO
березень '22
+65
в 0 каналах
Get PRO
лютий '22
+26
в 0 каналах
Get PRO
січень '22
+56
в 0 каналах
Get PRO
грудень '21
+44
в 0 каналах
Get PRO
листопад '21
+39
в 0 каналах
Get PRO
жовтень '21
+61
в 0 каналах
Get PRO
вересень '21
+66
в 0 каналах
Get PRO
серпень '21
+65
в 0 каналах
Get PRO
липень '21
+96
в 0 каналах
Get PRO
червень '21
+120
в 0 каналах
Get PRO
травень '21
+130
в 0 каналах
Get PRO
квітень '21
+812
в 0 каналах
Дата
Залучення підписників
Згадування
Канали
21 листопада+3
20 листопада+11
19 листопада+2
18 листопада+18
17 листопада+4
16 листопада+14
15 листопада+19
14 листопада+10
13 листопада+15
12 листопада+5
11 листопада+17
10 листопада+21
09 листопада+4
08 листопада+12
07 листопада+23
06 листопада+2
05 листопада+17
04 листопада+17
03 листопада+22
02 листопада+76
01 листопада+8
Дописи каналу
Global Burden of Anorexia and Bulimia Continues to Rise https://jamanetwork.com/journals/jama/fullarticle/2857198 Anorexia and bulimia nervosa affected about 18 million people worldwide in 2023, and the burden is projected to increase through 2050, according to a study published in JAMA Psychiatry.
20 лист, 13:26

2
Delirium During Hospitalization Linked to Long-Term Cognitive Decline https://jamanetwork.com/journals/jama/fullarticle/2857199 Hospital delirium was associated with substantially higher risks of mild cognitive impairment, dementia, and faster cognitive decline, according to a study published in JAMA Neurology.
337
3
CDC Imposes New Ebola-Related Air Travel Regulations https://jamanetwork.com/journals/jama/fullarticle/2857200 The US Centers for Disease Control and Prevention (CDC) issued new air travel requirements intended to reduce the risk of Ebola importation into the US during the ongoing outbreak in the Democratic Republic of the Congo (DRC).
340
4
JAMA Editors' Summary Podcast November 20, 2026 https://jamanetwork.com/journals/jama/fullarticle/2857227 Listen to the JAMA Editor’s Summary for an overview and discussion of the important articles appearing in JAMA.
322
5
Global Burden of Disease Assessment of Elevated LDL-C https://jamanetwork.com/journals/jama/fullarticle/2857043 To the Editor The Global Burden of Disease 2023 LDL Cholesterol Collaborators provided a timely assessment of the worldwide cardiovascular burden attributable to elevated low-density lipoprotein cholesterol (LDL-C). The finding that this burden is shifting toward middle sociodemographic index (SDI) settings is especially relevant for prevention. We would welcome clarification of 1 analytical choice.
478
6
Trends in Menopause Hormone Therapy https://jamanetwork.com/journals/jama/fullarticle/2857044 This cross-sectional study uses national pharmacy dispensing data to examine menopause hormone therapy dispensing in the US, including by age group as well as formulation and route.
431
7
Some Anniversaries of 1926 https://jamanetwork.com/journals/jama/fullarticle/2857045 From a nationalistic standpoint, the year 1926 has afforded opportunity for notable anniversary celebrations. In this country the sesquicentennial of the declaration of the independence of the United States has assumed the greatest prominence. The history of medicine also affords occasion for retrospect and commemoration. In 1776, the year brought so conspicuously into the public mind at the present time, the Prussian army surgeon Jasser successfully operated on the mastoid; Cruikshank of Edinburgh investigated the reunion and regeneration of severed nerves, and showed that they will grow together again, and Scheele isolated uric acid from the urine.
424
8
Pediatric Medical Imaging and Brain Tumor Risk https://jamanetwork.com/journals/jama/fullarticle/2857046 Computed tomography (CT) and other imaging modalities that use ionizing radiation are central to pediatric care, allowing rapid evaluation of congenital abnormalities, head trauma, acute neurologic deficits, and serious illness. Children require particular attention in radiation protection because their developing tissues are more radiosensitive and their longer life expectancy allows more time for radiation-related cancer to emerge.
372
9
Anemia and Iron Status in Pregnant and Postpartum Women With Acute Heart Failure https://jamanetwork.com/journals/jamacardiology/fullarticle/2856895 This case-control study investigates associations of maternal anemia and iron status with acute heart failure in Indian women during pregnancy and post partum.
464
10
Effect of Acoramidis on Heart Failure-Related Health Status—Reply https://jamanetwork.com/journals/jamacardiology/fullarticle/2856896 In Reply We thank Faiz and Khan for their thoughtful comments on our analysis of health status in ATTRibute-CM. We agree with the central premise of both letters: integrating patient-reported health status with survival in a progressive, fatal disease is methodologically challenging. Death cannot be treated as simply a missing Kansas City Cardiomyopathy Questionnaire (KCCQ) observation, especially when most patients die of cardiovascular causes. There are no ideal statistical methods that account for data missing not at random. Accordingly, any longitudinal analyses incorporating missing data will have strengths and weaknesses, and require making different, unverifiable assumptions.
442
11
Effect of Acoramidis on Heart Failure–Related Health Status https://jamanetwork.com/journals/jamacardiology/fullarticle/2856897 To the Editor The secondary analysis by Sherrod and colleagues of the ATTRibute-CM randomized clinical trial demonstrated that acoramidis produced a statistically significant and clinically meaningful attenuation of decline in health status, as measured by the Kansas City Cardiomyopathy Questionnaire Overall Summary score (KCCQ-OS), among patients with transthyretin amyloid cardiomyopathy (ATTR-CM). The integration of survival and patient-reported outcomes into composite alive and well, alive and not worse, and alive and better categories represents a valuable contribution to the field, and I commend the authors for this comprehensive, patient-centered analysis. I wish to raise several methodological considerations that we believe merit clarification and that may help readers more accurately gauge the magnitude and generalizability of the reported benefit.
384
12
Effect of Acoramidis on Heart Failure–Related Health Status https://jamanetwork.com/journals/jamacardiology/fullarticle/2856898 To the Editor The study by Sherrod et al reported that acoramidis significantly slows down the decline in Kansas City Cardiomyopathy Questionnaire Overall Summary score (KCCQ-OS) vs placebo in transthyretin amyloid cardiomyopathy (ATTR-CM). It reveals a 9.9-point treatment difference at month 30 and meaningful gains in alive and well and alive and better outcomes. By integrating survival with patient-reported health status, the authors provide a more meaningful measure of benefit in a progressive, often fatal disease. However, we question whether the overall estimate depends on the chosen imputation strategy
319
13
Residual Peridevice Leak 45 Days After Left Atrial Appendage Occlusion https://jamanetwork.com/journals/jamacardiology/fullarticle/2856899 This cohort study evaluates the association between 45-day peridevice leak severity and long-term thromboembolic outcomes after left atrial appendage occlusion.
335
14
Blood-Based Biomarker Testing for Alzheimer Disease in US Clinical Practice https://jamanetwork.com/journals/jama/fullarticle/2856893 This cohort study examines the rates of blood-based biomarker testing for Alzheimer disease in US clinical practice, exploring patient characteristics, ordering clinician specialty, and diagnostic and treatment events.
444
15
Conversations With Vaccine-Hesitant Patients https://jamanetwork.com/journals/jama/fullarticle/2856894 This JAMA Insights discusses different ways for clinicians to approach conversations with vaccine-hesitant patients, including understanding patients’ attitude roots and empathetic refutational interviewing.
461
16
Digital Delivery of APOE and P-tau217 Results https://jamanetwork.com/journals/jamaneurology/fullarticle/2856813 This randomized clinical trial evaluates noninferiority of delivering apolipoprotein E and plasma phosphorylated tau 217 results digitally vs through a clinician.
533
17
Toward a Healthier Future Through Obesity Prevention and Care https://jamanetwork.com/journals/jama/fullarticle/2856764 This Special Communication discusses the nature of the obesity epidemic; strengths and weaknesses of current approaches to it, including GLP-1 drugs; and roles for different stakeholders.
611
18
Call for Papers on the Future of Obesity https://jamanetwork.com/journals/jama/fullarticle/2856969 With 1 in 7 people (1.1 billion) worldwide affected by obesity, the possibility of widespread, effective medical treatment for this chronic condition has catalyzed a field previously beset by a sense of fatalism. The glucagon-like peptide-1 (GLP-1) and multiple receptor agonist peptide and nonpeptide therapies have yielded weight loss outcomes exceeding what their most ardent proponents could have imagined. Yet the availability of these novel therapeutics is limited by access and adverse effects. Perhaps even more important, their integration into an overall strategy addressing the complex biological, behavioral, socioeconomic, and environmental factors underpinning overweight and obesity is nascent at best.
572
19
Blood Conservation and Choice in Surgical Transfusion https://jamanetwork.com/journals/jama/fullarticle/2856799 This Viewpoint discusses blood conservation and surgical transfusion, including patient blood management and bloodless medicine and surgery, among patients who refuse blood.
630
20
Alcohol Consumption During Pregnancy in the US—Reply https://jamanetwork.com/journals/jama/fullarticle/2856800 In Reply We thank Dr Fan and colleagues for their thoughtful letter and for engaging with our study, which reported an increasing trend in alcohol consumption during pregnancy in the US over the past 2 decades. As discussed by the authors, our descriptive results indicate that older maternal age and tobacco use were both notable correlates of any alcohol use, raising questions about overlapping exposure patterns and potential synergistic effects. While our study was designed to assess population-level trends and does not address etiologic aims directly, we are encouraged that the findings have raised other substantive research questions that could have important implications for prevention and practice.
630